ProCE Banner Activity

Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: An Update from ASCO

Podcast Episodes

Listen as Beth Sandy, MSN, CRNP, discusses some of the latest key data on immune checkpoint inhibitors (ICIs) in non-small-cell lung cancer (NSCLC) reported at the American Society of Clinical Oncology (ASCO) Annual Conference.

Released: June 27, 2022

Expiration: June 26, 2023

No longer available for credit.



Beth Sandy

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania


This activity is supported by educational grants from Bristol Myers Squibb; Genentech, a member of the Roche Group; Merck Sharp & Dohme Corp.; and Regeneron Pharmaceuticals, Inc and Sanofi.

Provided by

ProCE Banner


Bristol Myers Squibb

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc


Target Audience

Oncology NPs, PAs, and nurses


Beth Sandy, MSN, CRNP: consultant: Amgen, AstraZeneca, Janssen, Jazz, Merck, Takeda.



Additional Information

Program Medium

This program has been made available online.